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Objective: The in situ vein (ISV) bypass is uniquely suited to technical modifications designed to reduce the wound
morbidity of infrainguinal revascularization. A technique of “blind” valvulotomy and selective vein branch ligation was
used, and a preliminary study was performed to assess safety and efficacy.
Methods: From November 1998 to July 2001, all patients for infrainguinal bypass procedures underwent evaluation for
inclusion in the study. Thirty-five patients underwent ISV bypass procedures with an expandable, selfcentering
valvulotome (ESV). Intraoperative selection of veins suitable for the study was assisted with venography and duplex
scanning. The ISV bypass procedures were performed with initial groin and distal incisions, with smaller incisions to
ligate significant arteriovenous fistulae (AVF). Duplex graft scanning was performed at routine intervals after surgery.
Results: Thirty-seven ISV grafts were performed from the common femoral artery to the popliteal (n  14), tibial (n 
20), and dorsalis pedis (n  3) arteries. In 35 cases (95%), a full-length incision was avoided. With ESV, all valves in 34
cases (92%) were effectively lysed. Proximal extension of the distal incision was performed in four cases (10.8%). The mean
number of incisions per case was 3.1  1.7. One graft failed within 30 days (2.7%), with successful revision. During the
early follow-up period (9.9  7.3 months; range, 1 to 33 months), 44% of residual AVF closed spontaneously (15 of 34
AVF; 16 patients) and two anastomotic stenoses and two symptomatic AVF were corrected surgically. Four late graft
occlusions occurred, with a 1-year cumulative primary patency rate of 77% and a secondary patency rate of 92%.
Conclusion: Blind valvulotomy with ESV facilitates safe and effective minimally invasive ISV bypass. Resultant graft
patency rates appear comparable with results with open techniques. This preliminary experience warrants further study
to refine patient selection criteria and operative technique and to better clarify the natural history of residual AVF. (J Vasc
Surg 2002;35:1100-6.)
Since its introduction by Hall in 1962,1 in situ bypass
with greater saphenous vein (GSV) has been shown to be a
durable strategy for treatment of lower limb arterial dis-
ease.2-4 However, conventional infrainguinal in situ bypass
accrues the morbidity of a full-length leg incision during
preparation of GSV for use as a conduit.5,6 In addition, in
situ bypass has no patency advantage over other techniques
of autogenous vein grafting.7-13 Current efforts to refine
in situ bypass use new technology to take advantage of the
unique potential of its anatomic configuration, which may
allow minimally invasive surgery for many patients with
infrainguinal arterial disease.
For limitation of incisional complications associated
with in situ grafting, angioscopy and duplex ultrasound
scan have been used to advantage, with early and midterm
reports that appear to show reduced wound morbidity rate
and hospital length of stay (LOS) without compromise of
patency.14-18 Instrumentation has been designed in an
effort to make direct visualization of valves and branches
with relatively costly equipment unnecessary. Previous
work has shown, however, that such “blind” valvulotomy
may be associated with an 85% incidence rate of vein injury
and an 18.9% incidence rate of residual competent valves.19
In this study, we examined an expandable, self-centering
valvulotome (ESV) that was designed to provide constant
yet atraumatic contact with the vein wall. Herein, we de-
scribe the preliminary results of a strategy for minimally
invasive infrainguinal in situ bypass with the ESV for blind
retrograde valvulotomy.
METHODS
From November 1998 to July 2001, patients for in-
frainguinal arterial reconstruction who had ipsilateral GSV
underwent evalution for inclusion in a protocol to assess the
use of blind valvulotomy for in situ vein (ISV) bypass.
Selection criteria included GSV of adequate length to reach
the distal target artery, uniformly adequate undistended
vein caliber of more than 3.0 mm determined with supine
duplex ultrasound scan or intraoperative venogram results,
and absence of anomalies that cause angulation and tortu-
osity of the dominant vein channel. The 2.7 mm-diameter
or 2.0 mm-diameter Lemaitre ESV (Vascutech, Burling-
ton, Mass) used in this study was designed with four
spring-mounted cutting blades oriented at 90 degrees for
retrograde valvulotomy. All patients underwent preopera-
tive aspirin therapy (81 to 325 mg/day), which was con-
tinued indefinitely after surgery.
Study data were recorded prospectively and analyzed
retrospectively. Data included patient characteristics, indi-
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cations for operation, intraoperative variables, such as num-
ber of incisions, technical feasibility, and details of valve
lysis and vein branch/arteriovenous fistula (AVF) ligation.
Postoperative information included wound morbidity and
other complications, LOS, persistent AVF, and graft pa-
tency as assessed with serial duplex ultrasound scan study
and clinical follow-up examination. Duplex ultrasound scan
examinations were routinely scheduled 1 month after sur-
gery, at three monthly intervals for the 1st year and at six
monthly intervals thereafter. Findings of reduction in over-
all graft flow velocity to less than 40 cm/s or regions of
increased peak systolic flow velocity to a ratio more than 3.5
compared with the adjacent vein were reasons for further
evaluation with arteriography.
Patients were declared lost to follow-up examination if
no patient contact had occurred within 12 months. Limb
salvage was defined as freedom from major amputation
through the calf or thigh. Primary patency rate was defined
in accordance with suggested reporting standards of the Ad
Hoc Committee of the Society for Vascular Surgery and the
North American Chapter of the International Society for
Cardiovascular Surgery.20 Thus, reoperation for AVF liga-
tion was not included in calculations of patency and reop-
eration for anastomotic stenosis was included. Cumulative
graft patency was calculated with the life table method, with
standard errors calculated with the Greenwood method.
Continuous variables were compared with Student t test.
Mean  standard deviation values are reported. A P value
of less than .05 was considered statistically significant.
Operative technique. Intraoperative selection of suit-
able veins was made with transcutaneous and direct palpa-
tion and visual inspection, assisted with supine venography
and duplex ultrasound scanning. When venography was
used, the distal end of the GSV was exposed at the ankle
and a 20-gauge catheter was inserted and secured. A ra-
diopaque measuring marker (Vascutech) was secured to the
leg adjacent to the course of the GSV. Full-strength iodin-
ated contrast material (30 to 50 mL) was hand injected via
the distal catheter to obtain images of the vein from distal
calf to mid thigh level. A groin incision was made to
mobilize the proximal GSV and common femoral artery.
The distal GSV and target artery were exposed through the
same incision when possible, mobilizing the vein suffi-
ciently for rerouting to the outflow artery as necessary. The
patient underwent systemically heparinization with 5000
units intravenously.
The proximal anastomosis was constructed after de-
tachment of the proximal GSV at the saphenofemoral junc-
tion and excision of the leaflets of the most proximal valve
with direct vision. Proximal clamps then were released,
which allowed flow into the vein to the first competent
valve. The distal GSV then was ligated and divided, fol-
lowed by gentle dilation of the vein with infusion of hepa-
rinized saline solution containing papaverine hydrochlo-
ride. The ESV then was introduced through the distal end
of the GSV and passed proximally to the level of the
proximal anastomosis. The cutting blades were deployed,
and the device was slowly withdrawn to just above the end
of the GSV. The cutters were resheathed, and the ESV
again was advanced to the proximal anastomosis. After
rotation 45 degrees, the cutters were deployed and the
device was withdrawn and removed after resheathing just
above the distal end of the vein. The Mills valvulotome then
was used to fracture remaining valve leaflets in the distal
GSV. The end of the vein was occluded with a bulldog
clamp. Sterile continuous wave Doppler scan then was used
to survey the proximal vein for AVF, with a technique
previously described.21 Branches that caused flow through-
out diastole were defined as significant and were exposed
through existing incisions or through short longitudinal
incisions and ligated. Branches that did not cause pandias-
tolic flow were marked at the skin level with a skin staple.
The bulldog was released from the end of the vein. If
pulsatile flow emerged at a vigorous rate, no further instru-
mentation was performed. If poor flow existed, the ESV
was passed once again to lyse residual valve leaflets. The
vein was occluded once again, and the distal anastomosis
was created with tourniquet inflow occlusion. Continuous
wave Doppler scan then was used to repeat the survey of
previously marked or new AVF, once again ligating any
AVF that allowed pandiastolic flow. When available, duplex
ultrasound scan was used to assist in review of the vein and
anastomotic regions. Completion angiography was rou-
tinely performed with 30 to 50 mL of full strength contrast
via a 20-gauge catheter inserted into the proximal vein
graft. Any residual AVF that caused prompt filling of the
deep venous system was exposed and ligated. Any technical
imperfections, strictures, or suspicious lesions that sug-
gested residual valve leaflets were addressed and revised as
necessary. Wounds were closed with subcutaneous absorb-
able suture and skin staples.
RESULTS
Thirty-seven in situ infrainguinal graft procedures with
ESV were performed in 35 patients. The study consisted of
22 male and 13 female patients with a mean age of 68.5 
13.4 years. Patients had the expected risk factors for ath-
erosclerotic disease and its systemic effects (Table I). Indi-
cations for operation were disabling claudication (n  3),
rest pain (n  8), and necrosis (n  26). One patient had
undergone a previous femorofemoral bypass procedure to
the ipsilateral femoral artery, another had undergone a
previous aortobifemoral bypass procedure, and a third had
undergone adjunctive common femoral aneurysm resec-
tion and grafting. The only secondary reconstruction was in
a patient who had a failed femoropopliteal prosthetic bypass
but a GSV that was suitable for in situ bypass. The proximal
anastomosis was constructed in the groin in all cases. The
distal anastomosis was to the above-knee popliteal artery in
four grafts, the below-knee popliteal artery in 10 grafts, the
tibial vessels in 20 grafts, and the dorsalis pedis in three
grafts.
The GSV was assessed during surgery with palpation
and direct inspection, assisted with venography (n  12),
with duplex ultrasonography (n  7), and with combined
duplex scan and venography (n  1). The ESV was passed
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a mean number of 2.2  0.5 times (range, 1 to 4) to
provide pulsatile vigorous outflow from the end of the vein.
A mean number of 2.4 1.8 vein branches (range, 0 to 7)
were ligated with selection criteria as described. In two
grafts (5.4%), the valve cutters were inadvertently deployed
within the hood of the proximal anastomosis, which re-
sulted in a linear tear in the hood of the graft repaired with
patch angioplasty in one case and in disruption of the
anastomotic suture line repaired with a stitch in the other
case. One patient underwent proximal extension of the
distal incision to allow direct visualization of ESV valvulot-
omy when vein duplication was noted at the time of dissec-
tion of the distal GSV; the ESV cleared all valves in the
exposed segment without incident. In five instances
(13.5%), the incision was lengthened to provide wider
exposure of the vein for investigation of poor flow through
the graft after ESV valvulotomy. The entire vein was ex-
posed through a continuous incision in two cases. In both
instances, the vein was found to be less than 3.5 mm in
diameter and use of a Mills valvulotome to lyse residual
valve leaflets resulted in satisfactorily improved flow. In two
cases, the Mills valvulotome detected no unlysed valve
leaflets, but an AVF was found and ligated with satisfactory
improvement in flow. In the third case (patient TB), the
Mills valvulotome encountered one residual uncut valve
located at a slight angulation in the vein and missed with
the 2.0-mm ESV. With exclusion of the two cases that were
converted to full-length leg incisions, the mean number of
incisions was 3.1  1.7 per bypass. Measurements of skin
incision length compared with preserved intervening skin
were made in nine patients, with an average of 50% (range,
40% to 61%) of the distance between the proximal end of
the groin incision and the distal end of the distal incision
remaining uncut. Mean operating time was 221.6  50.4
minutes.
One patient had calf wound debridement at the time of
bypass, followed by interval skin grafting during the same
hospitalization. Six patients underwent toe amputations in
conjunction with the revascularization procedure. One pa-
tient with a patent femoroperoneal in situ bypass needed a
pedal extension 6 days later to augment perfusion to toe
amputation sites. No patient underwent below-knee or
above-knee amputation during the perioperative and fol-
low-up periods.
Two deaths (5.4%) occurred within 30 days of surgery,
one from myocardial infarction at 3 days and one from
ischemic colitis at 21 days. Major morbidity occurred after
three procedures (8.1%): nonfatal myocardial infarction in
two instances and readmission for lower gastrointestinal
bleed as the result of coagulopathy and diverticulosis in one
case. Deep groin wound infections necessitating antibiotics
and dressing changes occurred after three procedures
(8.1%). Mild incisional erythema treated with oral antibiot-
ics alone was noted after three additional procedures. No
instances of “flap” necrosis or graft revision for exposed
conduit were seen. Two patients had a pattern of noninci-
sional linear erythema and induration representing phlebi-
tis of a subcutaneous GSV side branch. One bypass had
distal occlusion (see subsequent) within 30 days of surgery,
for an early postoperative graft failure rate of 2.7%.
Overall mean hospital LOS was 9.7  6.6 days (range,
3 to 29 days), with a mean postoperative LOS of 8.2 6.2
days (range, 3 to 29 days). All patients were ambulatory at
discharge; 18 patients (49%) were discharged to a rehabil-
itation facility and 17 patients (46%) were discharged di-
rectly home. With exclusion of the two patients who died
before discharge, mean postoperative LOS after surgery for
claudication or rest pain (n  11) was 5.2  1.7 days
(range, 3 to 8 days) compared with 9.2  6.7 days (range,
4 to 29 days) after surgery for necrosis (ulcer or gangrene;
n  24; P  .01). Exclusion of the three patients who
needed postoperative bypass revision, AVF ligation, or skin
grafting reduced the mean postoperative LOS to 6.5 3.4
days (n 32; range, 3 to 17 days). Additional exclusion of
the two patients with myocardial infarction reduced the
mean postoperative LOS further to 5.9 2.2 days (n 30;
range, 3 to 14 days).
The mean follow-up period of the 35 operative survi-
vors was 9.9  7.3 months (range, 1 to 33 months), with
data available on 31 patients (89%) within 12 months of
reporting. At duplex ultrasound scan 1 to 3 months after
surgery, 34 AVF were identified in 16 limbs (45.7%) among
the 35 patients who survived surgery (Table II). By the
follow-up examination at 4 to 18 months after surgery, 15
of the AVF (44%) had spontaneously closed. Of the remain-
der, seven remained patent in six patients with no signifi-
cant symptoms or objective clinical signs. Ten AVF were
ligated at a mean interval of 4 months. A bothersome thrill
was the indication for ligation of two AVF in one patient,
and three asymptomatic AVF were ligated incidental to
graft revision for neointimal hyperplasia in two patients.
Two new AVF were noted within 8 days after surgery in a
patient with a patent bypass and ankle-brachial index of
0.43, with ligation resulting in change of ankle-brachial
index to 0.53. Finally, three AVF were found 3 weeks after
surgery in a patient whose distal femoroperoneal graft
Table I. Characteristics of 35 patients who underwent
in situ bypass procedures
No.
Male 22 (62.9%)
Female 13 (37.1%)
Mean age 68.5  13.4 years
Coronary artery disease 18 (51.4%)
Tobacco use
Current 4 (11.4%)
Former 15 (42.9%)
Diabetes mellitus 19 (54.3%)
Dialysis dependence 7 (20.0%)
Dyslipidemia 15 (42.9%)
Hypertension 25 (71.4%)
Cerebrovascular disease 21 (60.0%)
No. of comorbidities
3 34.3%
4 34.3%
5 17.1%
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occluded with preservation of the graft to the knee level by
virtue of fistula flow. The distal vein had been found
angulated and of small caliber at the time of bypass with the
2.0-mm ESV. Ligation of the AVF and replacement of the
distal segment with an end-to-end vein interposition to the
same outflow anastomosis resulted in reocclusion within 1
day, necessitating successful repeat surgery with a vein
interposition graft to the anterior tibial artery.
The 1-year cumulative primary patency rate was 77%
8%, with the exclusion of reoperations for AVF ligation.
Two grafts had three patch angioplasties for anastomotic
stenosis detected at 6 weeks and 8 months. One graft had
vein interposition at 5 months for a short stricture adjacent
to a reincised valve cusp (patient TB) in the distal portion of
the bypass. Including these three revisions for stenosis, the
cumulative 1-year primary-assisted patency rate was 89%
6%. Five grafts occluded during the follow-up period (Ta-
ble III), with one revision yielding a cumulative secondary
patency rate of 92%  5% at 1 year. In addition to the two
early postoperative deaths, four patients died during the
late postoperative follow-up period.
DISCUSSION
These preliminary data suggest that blind valvulotomy
in conjunction with a Doppler scan-based protocol for
identification of potentially hemodynamically significant
AVF may be a safe and effective technique for minimally
invasive in situ infrainguinal bypass. Vein injury was de-
tected in two of 37 vein grafts (5.4%), with both injuries
resulting from a deployment of the cutting head within the
hood of the proximal anastomosis. This compares favorably
with previously reported rates of vein wall injury during
blind valvulotomy ranging from 17% to 85%.19,22 Minor
intimal defects that were counted in previous studies with
completion angioscopy may have been missed with the
present strategy with duplex scan, angiography, and Dopp-
ler ultrasound scan to assess the completed vein graft. More
significant intimal disruptions leading to longer hyperplas-
tic stenoses were not noted on routine follow-up duplex
scanning or angiography when performed for patients with
significant duplex scan findings. In the case of one patient
whose graft occluded at 3 weeks after surgery, the ESV and
Table II. Natural history of 34 AVF in 16 patients
Patient
Distal
anastomosis
Postoperative
AVF
Follow-up
interval Comment
JB Popliteal 3 20 months Unligated, asymptomatic
MR Tibial 2 2 months 2 ligated during revision of distal anastomosis
PR Tibial 3 13 months 1 spontaneous closure, 2 ligated for bothersome thrill
AC Peroneal 2 1 week Ligated for postoperative ABI 0.43; increased to 0.53 after ligation
MH Tibial 1 11 months Spontaneous closure
JM Peroneal 1 1 month Spontaneous closure
EG Tibial 3 7 months 1 spontaneous closure, 2 unligated, asymptomatic
JH Tibial 1 6 months Spontaneous closure
HS Tibial 3 12 months 2 spontaneous closure, 1 unligated, asymptomatic
FO Popliteal 3 4 months Spontaneous closure
FB Tibial 2 5 months 1 spontaneous closure, 1 ligated during jump graft revision of distal
vein graft stricture
CG Popliteal 1 6 months Spontaneous closure
BC Tibial 3 5 months Spontaneous closure
WM Peroneal 3 1 month Provided proximal runoff for distally occluded vein graft
MC Popliteal 2 3 months Unligated, asymptomatic
ABI, Ankle-brachial index.
Table III. Features of occluded infrainguinal in situ bypasses
Patient
Distal
anastomosis
Time to
failure Comment
MW Distal popliteal 20 months Lost inflow from previous femorofemoral bypass; no redo after graft failure, no
amputation at 30 months
JH Posterior tibial 15 months Severely diseased runoff vessel; graft without stenosis at 5 months; new femoral-peroneal
bypass with composite arm and leg vein
FS Posterior tibial 6 months Converted to full-length incision at first operation because of small vein/missed valves/
AVF; wound dehiscence at ankle; duplex scan without significant graft disease at 2
months; new femoral-plantar bypass with nonreversed vein patent at 3 months
WM Peroneal 3 weeks Extended distal incision at first operation because of small, angulated vein; proximal vein
patent via runoff through AVFs, dital vein occluded; first redo (jump graft from
midvein graft to peroneal); failed in 1 day, second redo midvein graft to anterior tibial
artery with arm vein, patent at 4 months
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Mills both were passed across an angulation at the nar-
rowed distal vein, leading to speculation that intimal injury
not apparent on the completion angiogram may have con-
tributed to this early graft failure.
The efficacy of this approach for blind valvulotomy is
supported with a 30-day graft failure rate of 2.7% and a
1-year primary patency rate of 77%, comparable with the
range reported for other techniques of in situ bypass.2-4,23
No residual valves were noted on completion studies, with
the inclusion of five grafts in which poor flow prompted
adjunctive use of a Mills valvulotome. In one case in which
the distal incision was extended and the Mills valvulotome
found a valve cusp just above an angulation, and in the two
cases that were converted to full-length incisions and Mills
valvulotomy, the vein caliber was noted to be less than 3.5
mm in the segments harboring uncut valve leaflets. This
limitation of valvulotome function may be corrected with
subsequent versions of the ESV that possess a smaller
housing for the cutting blades.
Evidence suggested causes of failure were possible val-
vulotome injury to small angulated vein at 3 weeks, small
vein and distal wound dehiscence/infection at 6 months,
poor anterior tibial runoff at 15 months, and loss of femo-
rofemoral inflow at 20 months, and no suggestive evidence
was seen in one instance of occlusion at 4 months. A
previous study of graft failure after in situ bypass has re-
ported 9.8% contribution with valvulotome injury to over-
all nonocclusive stenosis and occlusion in a large series.24
Although the exact cause of graft failure in this smaller pilot
study is indeterminate and likely to be multifactorial, no
suggestion exists of an untoward increase in valvulotome-
related graft failures from the collected clinical data. A
longer follow-up period would help clarify this point.
Overall graft failure also does not appear to be signifi-
cantly influenced by residual AVF that are inherent to the
protocol presented in this study. A spontaneous closure
rate of 44% was found during the mean follow-up period of
9.9  7.3 months, similar to that seen by other research-
ers.25,26 Of the two patients who underwent reoperation
for ligation of AVF, only one was noted to have a hemody-
namic decrement from persistent fistulae. Previous work
also has noted that AVF have no correlation with graft
failure25 or clinical symptoms of ischemia.27 Some re-
searchers have suggested that AVF may even enhance pa-
tency.26 Indeed, in the case of the one patient who had
distal occlusion of the vein graft, with the cause of failure
postulated to be related to possible valvulotome injury plus
angulation and small caliber of the vein, that the proximal
vein conduit patency was maintained with outflow to two
residual AVF is interesting to note. This patent proximal
vein graft then was able to be used for the jump graft
revision. In addition, one patient had an AVF that inciden-
tally preconditioned a large arterialized vein branch, which
then was conveniently used as an interposition graft when a
focal stricture of an already small distal vein necessitated
revision. Further work is necessary to characterize the rela-
tionships between anatomic size, physiologic flow, and
natural history of AVF and their relevance to graft function.
The limitations of this technique for minimally in situ
bypass relate to the selection of suitable vein, with an initial
requirement of the presence of an adequate ipsilateral GSV,
a criterion not satisfied in as much as 23% of patients.28
Which method, venography or duplex scanning, is better at
verification of the adequacy of vein size (3.5 mm) and
quality (absence of angulation or duplication) is unclear. A
new smaller (1.8-mm) cutting head for this ESV also might
possibly make smaller veins eligible for blind valvulotomy.
Interesting to note, however, is that even in this pilot study,
which included the learning curve for the technique, in
which there might be a lower threshold for reversion to the
conventional open procedure, there was a conversion rate
of only 5.4%. The combination of ESV with direct valvu-
lectomy of the most proximal valve and Mills valvulotomy
of the distal most vein conduit helps maintain the method
as minimally invasive yet effective at safely rendering valves
incompetent.
The wound morbidity rate of this approach appears to
be an improvement on previous reports after conventional
in situ bypass.5,6 In addition, this technique may avoid the
additional expense of angioscopic or duplex scanning
equipment. The protocol of Doppler ultrasound scan for
assessment of the vein for hemodynamically significant
AVF, with selective ligation of these vein branches, makes
this a potentially simple method. Data on hospital LOS as
presented here may be more influenced with patient vari-
ability than the possible effects of minimized leg incisions
on recovery after revascularization.
This study is primarily limited by the relatively short
and variable length of follow-up period. Although these
preliminary data are encouraging, further work is clearly
needed to assess the longer term outcomes of this particular
ESV device and the policy of leaving selected vein branches
open at the time of surgery. A more complete hemody-
namic assessment of effects of AVF during surgery (eg,
Doppler scan flow volume measurements) would aid a
prospective definition of important AVF. Further study,
with a more standardized assessment of the ESV valve-
cutting efficacy, will also be needed to define the selection
criteria for veins for which this ESV is appropriate. These
preliminary results with a protocol for blind valvulotomy
provide the rationale and impetus for further investigation.
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DISCUSSION
Dr Frank LoGerfo (Boston, Mass). I am trying to imagine
what it is like to use this device. You do your proximal anastomosis
and slide this up at that point, right?
Dr Sidhu Gangadharan. That is correct.
Dr LoGerfo. After that was done, you did 2.2 passes. How
do you decide how many passes to make?
Dr Gangadharan. The standard protocol was to pass it once
and then rotate it 45 degrees for the cutting blades to engage the
vein at a slightly different angle. Whether it was passed an addi-
tional time or not was dependent on basically the squirt test from
the end of the vein and what the flow was like after the large side
branches were ligated.
Dr David R. Campbell (Boston, Mass). Thank you very
much. I enjoyed this paper. I think, like many, I was alarmed by Dr
Cronenwett’s revelation of Medicare data showing that for the first
time in the history of vascular surgery in the last 5 years our
amputation rate is going up, not down. Some have postulated this
is due to age and other factors, though we have seen today some
patients with very severe disease with good results. Others have
noted that it is associated with increase of use of endovascular
techniques, though that obviously cannot be proven and we also
saw a paper today with no arteriography performed with a lower
than expected results. This is one of about four different ways of
using the minimal techniques to perform a standard procedure,
and none of them have really caught on in a big way. I used this
technique myself a number of times, and when it works well, it
works beautifully, but the occasions it did not work, I did damage
to this vein that perhaps I would not have done if I had used an
open technique. I would be interested to see whether you think
this is really the keeper or whether you are going to go on and do
a controlled study to evaluate this further. Certainly, it is very easy
to use when it works well, but my experience was that if it did not
and I had to open it up I was really concerned about creating more
trauma than I would otherwise have done. Thank you.
Dr Gangadharan. We share your concerns with the possibil-
ity of endothelial injury with this device. We do not look at the
inside of the vein with angioscopy, so our readout here will be
whether valves were retained and whether there was gross injury to
the vein and then indirectly what was the early graft failure rate and
what was at least the early patency data. Going out to a mean
follow-up period of 9.9 months, our patency data appear to be
adequate, meaning that we are not seeing an intimal hyperplastic
lesion that may have arisen from the injury caused by this valvu-
lotome in this small series, but with bigger series, those numbers
may indeed come out.
Dr Jack L. Cronenwett (Lebanon, NH). I have three ques-
tions. As you know, you can do a minimally invasive approach and
still lyse valves with direct vision with an angioscope, without
making a long incision. So, my first question is, what do you have
against the angioscope?
I have found that the multiple incision approach tends to
lengthen the procedure because of the difficulty in localizing small
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venous side branches through small incisions. We had found that
with preoperative vein mapping we have reduced our wound
complication rate associated with one long incision because it is
located accurately over the vein with no skin flaps. Have you
noticed any increase in your procedure length and where the
tradeoff is?
Finally, you reported that three grafts occluded distally but
patency was retained because of a patent AVF. In your follow-up
duplex scan surveillance, can you tell us that they did not occlude
because of that fistula? In other words, was the fistula reducing the
velocity in the distal graft prior to occlusion?
Dr LoGerfo. I am so glad that it was Dr. Cronenwett who
asked the question about angioscopy and not I.
Dr Gangadharan. I will address the last question first. Just to
clarify, only one graft was occluded distally with proximal patency.
It was maintained by three AVF, and it is a good question. We do
not know that the steal from those AVF did not contribute to the
occlusion of that graft, but I can tell you that the revision of that
graft subsequently did fail as well, which made us think that the
cause was poor runoff. A subsequent complete revision to another
runoff vessel remained open.
The question about the duration of the operation and whether
it was difficult to localize these small venous side branches, I think
we can look at in two ways. First, the average time of the operation
was 220 minutes. In 12 cases, venography was used prebypass to
localize the side branches, and in seven cases, duplex scan was used
to prebypass localize these side branches, which means that in
nearly half of the cases we just localized them with Doppler scan.
Using that strategy, I think our overall operating time was within
the realm of what we had with a complete open leg incision. The
other aspect of that is that with this technique you are not obli-
gated to ligate every single side branch and with that strategy in
mind you can cut down on some of the operating time.
Regarding the first question about angioscopy, there is really
no personal animosity, I believe, within the group against angios-
copy, but this was offered as a potential method for folks that do
not have angioscopy available or are desiring to try another tech-
nique that may be simple without learning and acquiring an
angioscope.
Dr Richard Murphy (Concord, NH). We actually have been
using this technique for a couple of years and have been very happy
with it. I will share with you that I have given up trying to do
selective ligation. I just do not have the patience and end up
making a leg length incision and tying off fistulae.
My question pertains to your statement, because I am inspired
to maybe try this again being selective. In the patients in whom you
found fistulae after surgery, you said those were clinically signifi-
cant. Could you expand on what criteria you use for determining
what is a clinically significant fistula?
Dr Gangadharan. Of the patients that had postoperative
revisions for decrease in graft flow or stenoses, those revisions were
done for anastomotic stenoses. The clinically significant fistulae
actually were clinically insignificant fistulae, meaning that in three
patients they had fistulae ligated but those fistulae were not causing
any clinically relevant symptoms, either a change in their symptom-
atology or a marked decrease in their follow-up duplex scan.
Dr Murphy. I guess that is what I am trying to get at. I
assume you follow these grafts in the vascular lab. What vascular lab
criteria do you use to evaluate these fistulae?
Dr Gangadharan. Unfortunately, with this retrospective re-
view, we were unable to have the actual hemodynamic or any
parameter like an ankle-brachial index to help guide us when
looking at that specific issue. I think in the future when we
investigate the significance of the AVF, we would like to have
baseline ankle brachial indexes and additionally we would like to
measure flow in the operating room to understand how much flow
is going through the AVF and the degree of flow through the
persistent AVF and what effect that might have on the eventual
outcome. We do not know those answers from these data.
Dr Baltej Maini (Worcester, Mass). I enjoyed your paper,
and I have a couple of comments. We have had an interest in a
minimally invasive technique for a number of years utilizing saphe-
nous vein mapping angioscopy and using multiple stab incisions to
ligate the tributaries. I am concerned about the veins that you are
leaving behind and not tying off or clipping. Why not spend a few
extra minutes and put on a few hemoclips and worry less later?
Secondly, have you considered using the blind technique and
then looking at the vein with an angioscope and ultimately corre-
lating that with long-term problems both in terms of patency and
graft stenoses?
Dr Gangadharan. Regarding the second question, we have
not at this time thought of using the angioscope to elucidate more
minor vein injury to track the potential effect of those vein injuries
on the long-term outcome. Certainly, when other groups have
looked at the use of blind valvulotomy, they have noticed a very
high rate of vein injury with the angioscope, but these vein injuries
are often minor intimal tears or furrows and the telling thing I
think is what the long-term behavior of that vein graft is. Is there a
long stricture or string sign that is associated with a vein injury, or
are all of the failures or all of the revisions secondary to something
that you would encounter with any technique, meaning an anas-
tomotic problem or a runoff problem?
The first question was whether we should tie off all of the vein
branches. I think that in this small series the majority of these cases
were done by one senior author. Others among the senior authors
did practice slightly more rigorous ligation of these fistulae, and I
think the point of this study was really to find out is it possible to
leave these behind and as some have suggested not see an unto-
ward effect on your patency.
Dr John J. Skillman (Boston, Mass). A Harvard medical
student once reminded me that language is a gift of the gods when
I made some grammatical faux pas, and I just wanted to point out
that veins have tributaries and arteries have branches. Dr Hopkins
and I were sitting there discussing this, and Dr Hopkins mentioned
that maybe you are talking about the arterialized vein.
Dr Randolph Maloney (Beverly, Mass). Since we are talking
about language, I would not call this minimally invasive either. I
mean a Gore-Tex femoral-popliteal bypass with a tunneler is
minimally invasive then. However, I actually rise to tell you that in
our private practice you either love or hate this. There are two of us
that do most of the femoral-popliteal bypasses. I happen to be an
advocate of this valvulotome, and as with all things in vascular
surgery, it takes a certain amount of finesse. If you are trying to just
yank this thing down and not feel and get all the tactical informa-
tion that you can get, you will screw up everything. You have to
know just like any other valvulotome you use that you may be hung
up on a branch or tributary and you need to stop and find it. If you
do preoperative ultrasound mapping, if you then use some finesse
in pulling this thing down, you will know whether you are lysing or
not. We might pass it two or three times. You neglected to mention
that there is saline inflow to help distend the vein as you bring it
down. That is a good trick to use to make sure the valves are open
as you bring the valvulotome down. There is a learning curve, and
there is a certain amount of finesse to use with it. And then we
always do confirmation with a postoperative angiogram, on the
table angiogram, to make sure that we have not left any valves. I
find it very useful; my associate hates it.
Dr Gangadharan. Thank you for your comments. I have
become aware of several similar sentiments within Boston itself
that several groups have liked this technique and the majority have
not. I think one of the reasons that prompted us to present it at this
forum was that there has not been a lot of discussion about this in
a forum such as this. That is part of the rationale for presenting this.
To clarify our technique with the use of saline, we actually did
not use saline to distend the vein and close the valves. We used the
pressure generated via the proximal anastomoses to close the valves
and cut down on potential saline irrigation and what not.
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